Related Experiment Video
Updated: Mar 13, 2026

06:49
Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates
Published on: May 8, 2020
5.3K
PKA Has the Gall to Oppose NLRP3
1Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Immunity
|October 21, 2016
Summary
Researchers discovered that bile acids act as natural inhibitors of the NLRP3 inflammasome, a key player in inflammatory diseases. This finding offers potential new therapeutic targets for managing inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Gastroenterology
Background:
- The NLRP3 inflammasome is implicated in various inflammatory diseases.
- Identifying endogenous inhibitors of NLRP3 is crucial for therapeutic development.
Purpose of the Study:
- To investigate potential endogenous negative regulators of the NLRP3 inflammasome.
- To explore the role of bile acids in modulating NLRP3 inflammasome activation.
Main Methods:
- The study likely involved in vitro assays to assess inflammasome activation.
- Experiments may have utilized cell-based models and biochemical analyses.
Main Results:
- Bile acids were identified as potent negative regulators of the NLRP3 inflammasome.
- This suggests a novel mechanism by which the body controls inflammatory responses.
Conclusions:
- Bile acids represent a new class of endogenous inhibitors for the NLRP3 inflammasome.
- Targeting bile acid metabolism or signaling could offer therapeutic strategies for inflammatory conditions.
More Related Videos
Related Concept Videos
IP3/DAG Signaling Pathway
15.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.5K
Nucleophiles
17.3K
The word “nucleophile” has a Greek root and translates to nucleus-loving. Nucleophiles are either negatively charged or neutral species with a pair of electrons in a high-energy occupied molecular orbital (HOMO). As these species tend to donate electron pairs, nucleophiles are considered Lewis bases as well. Negatively charged species, like OH−, Cl−, or HS−, with one or several pairs of electrons, are typically nucleophiles. Similarly, neutral species such as...
17.3K
GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Cell Signaling in Plants
6.9K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
6.9K
GPCR Desensitization
8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K

